IBSRELA

Identification of Ibsrela

No description

Google image searchProduct monograph

Active ingredient

tenapanor (tenapanor hydrochloride), 50 MG

DIN: 02498049

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: KNIGHT THERAPEUTICS INC.

Date: 23-NOV-2020

ATC:

Search on Google